Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided Injection for Mild to Moderate Carpal Tunnel Syndrome
NCT07825155Phase 1Recruiting
- Sponsor
- Tanta University
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial of hyaluronic acid, triamcinolone acetonide and glucose in carpal tunnel syndrome (CTS) (3 arms), sponsored by Tanta University. Primary endpoint: Change in median nerve cross-sectional area at 3 months. Started Mar 2026; status: recruiting.
02
Drugs
hyaluronic acidtriamcinolone acetonideglucose
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT07825155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07825155.